Nippon India Pharma Fund(G)

224.53 -0.82 (-0.37%) NAV as on 23-Oct-20
52-Week High ( ) 236.46 (08-Oct-20)
52-Week Low ( ) 130.37 (23-Mar-20)
Type Open ended scheme
Launch Date 05-Jun-04
Net Assets ( Cr ) 3910.67
Max Entry Load (%) 0.00
Max Exit Load (%) 0.00
Minimum Investment ( ) 5000

PERFORMANCE

Returns 6M (%) 1Y (%) 3Y (%) Since INC.
Scheme Return24.6056.1919.3320.90
Category Avg28.7558.5615.8222.97
Category Best-0.765.063.2019.46
Category Worst-6.89-3.39-6.39-4.00
SENSEX27.694.167.77-
BSE HC29.1852.6911.81-
NIFTY28.092.815.41-

Performance GRAPH

More from Perfomance »

Portfolio Summary

Name of Holding Instrument Hold (%)
Lupin Ltd.Domestic Equities10.3
Aurobindo Pharma Ltd.Domestic Equities10
Sun Pharmaceutical Industries Ltd.Domestic Equities9.73
Dr. Reddys Laboratories Ltd.Domestic Equities9.62
Divis Laboratories Ltd.Domestic Equities9.35
More from Portfolio Summary »

INvestment Pattern Details

Type Minimum Maximum
Equity and Equity related Instruments of companies in Pharma Sector80100
Debt & MMI020
Units issued by REITs and InvITs010
More from Investment Pattern Details »

Return Calculator

MARKET STATS As on 23/10/2020 As on 23/10/2020

11930.35 (0.28) 40685.50 (0.31)

TOP GAINERS

Company Price Change Gain (%)
Consolidated Constn.0.200.0533.33
Menon Bearings52.808.8020.00

TOP LOSERS

Company Price Change Loss (%)
Diligent Media Corpn0.35-0.05-12.50
Castex Technologies0.45-0.05-10.00

Portfolio Comparison

MUTUAL FUND ACTIVITY